Intraoperative Fluid Balance and Perioperative Complications in Ovarian Cancer Surgery

Background Fluid overload and hypovolemia promote postoperative complications in patients undergoing cytoreductive surgery for ovarian cancer. In the present study, postoperative complications and anastomotic leakage were investigated before and after implementation of pulse pressure variation-guide...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of surgical oncology 2024-12, Vol.31 (13), p.8944-8951
Hauptverfasser: Egger, Eva K., Ullmann, Janina, Hilbert, Tobias, Ralser, Damian J., Padron, Laura Tascon, Marinova, Milka, Stope, Matthias, Mustea, Alexander
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 8951
container_issue 13
container_start_page 8944
container_title Annals of surgical oncology
container_volume 31
creator Egger, Eva K.
Ullmann, Janina
Hilbert, Tobias
Ralser, Damian J.
Padron, Laura Tascon
Marinova, Milka
Stope, Matthias
Mustea, Alexander
description Background Fluid overload and hypovolemia promote postoperative complications in patients undergoing cytoreductive surgery for ovarian cancer. In the present study, postoperative complications and anastomotic leakage were investigated before and after implementation of pulse pressure variation-guided fluid management (PPVGFM) during ovarian cancer surgery. Patients and Methods A total of n  = 243 patients with ovarian cancer undergoing cytoreductive surgery at the University Hospital Bonn were retrospectively evaluated. Cohort A (CA; n  = 185 patients) was treated before and cohort B (CB; n  = 58 patients) after implementation of PPVGFM. Both cohorts were compared regarding postoperative complications. Results Ultrasevere complications (G4/G5) were exclusively present in CA ( p  = 0.0025). No difference between cohorts was observed regarding severe complications (G3–G5) ( p  = 0.062). Median positive fluid excess was lower in CB ( p  = 0.001). This was independent of tumor load [peritoneal cancer index] ( p  = 0.001) and FIGO stage ( p  = 0.001). Time to first postoperative defecation was shorter in CB (CB: d2 median versus CA: d3 median; p  = 0.001). CB had a shorter length of hospital stay ( p  = 0.003), less requirement of intensive medical care ( p  = 0.001) and postoperative ventilation ( p  = 0.001). CB received higher doses of noradrenalin ( p  = 0.001). In the combined study cohort, there were more severe complications (G3–G5) in the case of a PFE ≥ 3000 ml ( p  = 0.034) and significantly more anastomotic leakage in the case of a PFE ≥ 4000 ml ( p  = 0.006). Conclusions Intraoperative fluid reduction in ovarian cancer surgery according to a PPVGFM is safe and significantly reduces ultrasevere postoperative complications. PFEs of ≥ 3000 ml and ≥ 4000 ml were identified as cutoffs for significantly more severe complications and anastomotic leakage, respectively.
doi_str_mv 10.1245/s10434-024-16246-0
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11549190</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3114499946</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-2328e235fde808d95c0af99be08dc2461d7bcfe8e04491eb19f5a447ec2ce64f3</originalsourceid><addsrcrecordid>eNp9UU1PHDEMjVCrQmn_AIdqpF64TMn3JKeqrEqLhAQSlGuUzXho0GyyTXZW4t_jZfkoPfSU2H5-9vMj5IDRL4xLdVQZlUK2lMuWaS51S3fIHlOYktqwN_in2rSWa7VL3td6SynrBFXvyK6worOdMXvk-jStis9LKH4V19CcjFPsm2M_-hSg8alvLqDEl_osL5ZjDBjkVJuYmvO1L9GnZrZpKM3lVG6g3H0gbwc_Vvj4-O6TXyffr2Y_27PzH6ezb2dtEEqvWi64AS7U0IOhprcqUD9YOwcMAipifTcPAxigUloGc2YH5aXsIPAAWg5in3zd8i6n-QL6ABs1o1uWuPDlzmUf3etKir_dTV47xhQyWooMh48MJf-ZoK7cItYAIx4A8lSdYAxnWys1Qj__A73NU0moD1FcM2M5NYjiW1QoudYCw_M2jLqNb27rm0Pf3INvbrPFp791PLc8GYUAsQVULCU88cvs_9DeA3hGpM8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3126189208</pqid></control><display><type>article</type><title>Intraoperative Fluid Balance and Perioperative Complications in Ovarian Cancer Surgery</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Egger, Eva K. ; Ullmann, Janina ; Hilbert, Tobias ; Ralser, Damian J. ; Padron, Laura Tascon ; Marinova, Milka ; Stope, Matthias ; Mustea, Alexander</creator><creatorcontrib>Egger, Eva K. ; Ullmann, Janina ; Hilbert, Tobias ; Ralser, Damian J. ; Padron, Laura Tascon ; Marinova, Milka ; Stope, Matthias ; Mustea, Alexander</creatorcontrib><description>Background Fluid overload and hypovolemia promote postoperative complications in patients undergoing cytoreductive surgery for ovarian cancer. In the present study, postoperative complications and anastomotic leakage were investigated before and after implementation of pulse pressure variation-guided fluid management (PPVGFM) during ovarian cancer surgery. Patients and Methods A total of n  = 243 patients with ovarian cancer undergoing cytoreductive surgery at the University Hospital Bonn were retrospectively evaluated. Cohort A (CA; n  = 185 patients) was treated before and cohort B (CB; n  = 58 patients) after implementation of PPVGFM. Both cohorts were compared regarding postoperative complications. Results Ultrasevere complications (G4/G5) were exclusively present in CA ( p  = 0.0025). No difference between cohorts was observed regarding severe complications (G3–G5) ( p  = 0.062). Median positive fluid excess was lower in CB ( p  = 0.001). This was independent of tumor load [peritoneal cancer index] ( p  = 0.001) and FIGO stage ( p  = 0.001). Time to first postoperative defecation was shorter in CB (CB: d2 median versus CA: d3 median; p  = 0.001). CB had a shorter length of hospital stay ( p  = 0.003), less requirement of intensive medical care ( p  = 0.001) and postoperative ventilation ( p  = 0.001). CB received higher doses of noradrenalin ( p  = 0.001). In the combined study cohort, there were more severe complications (G3–G5) in the case of a PFE ≥ 3000 ml ( p  = 0.034) and significantly more anastomotic leakage in the case of a PFE ≥ 4000 ml ( p  = 0.006). Conclusions Intraoperative fluid reduction in ovarian cancer surgery according to a PPVGFM is safe and significantly reduces ultrasevere postoperative complications. PFEs of ≥ 3000 ml and ≥ 4000 ml were identified as cutoffs for significantly more severe complications and anastomotic leakage, respectively.</description><identifier>ISSN: 1068-9265</identifier><identifier>ISSN: 1534-4681</identifier><identifier>EISSN: 1534-4681</identifier><identifier>DOI: 10.1245/s10434-024-16246-0</identifier><identifier>PMID: 39379788</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Anastomotic leak ; Anastomotic Leak - etiology ; Cancer surgery ; Complications ; Cytoreduction Surgical Procedures - adverse effects ; Defecation ; Female ; Fluid Therapy ; Follow-Up Studies ; Gynecologic Oncology ; Humans ; Intraoperative Complications - etiology ; Length of Stay ; Medicine ; Medicine &amp; Public Health ; Middle Aged ; Oncology ; Ovarian cancer ; Ovarian Neoplasms - pathology ; Ovarian Neoplasms - surgery ; Patients ; Postoperative ; Postoperative Complications - etiology ; Prognosis ; Retrospective Studies ; Surgery ; Surgical anastomosis ; Surgical Oncology ; Water-Electrolyte Balance</subject><ispartof>Annals of surgical oncology, 2024-12, Vol.31 (13), p.8944-8951</ispartof><rights>The Author(s) 2024</rights><rights>2024. The Author(s).</rights><rights>The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2024 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c356t-2328e235fde808d95c0af99be08dc2461d7bcfe8e04491eb19f5a447ec2ce64f3</cites><orcidid>0000-0002-9891-3996</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1245/s10434-024-16246-0$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1245/s10434-024-16246-0$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,27923,27924,41487,42556,51318</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39379788$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Egger, Eva K.</creatorcontrib><creatorcontrib>Ullmann, Janina</creatorcontrib><creatorcontrib>Hilbert, Tobias</creatorcontrib><creatorcontrib>Ralser, Damian J.</creatorcontrib><creatorcontrib>Padron, Laura Tascon</creatorcontrib><creatorcontrib>Marinova, Milka</creatorcontrib><creatorcontrib>Stope, Matthias</creatorcontrib><creatorcontrib>Mustea, Alexander</creatorcontrib><title>Intraoperative Fluid Balance and Perioperative Complications in Ovarian Cancer Surgery</title><title>Annals of surgical oncology</title><addtitle>Ann Surg Oncol</addtitle><addtitle>Ann Surg Oncol</addtitle><description>Background Fluid overload and hypovolemia promote postoperative complications in patients undergoing cytoreductive surgery for ovarian cancer. In the present study, postoperative complications and anastomotic leakage were investigated before and after implementation of pulse pressure variation-guided fluid management (PPVGFM) during ovarian cancer surgery. Patients and Methods A total of n  = 243 patients with ovarian cancer undergoing cytoreductive surgery at the University Hospital Bonn were retrospectively evaluated. Cohort A (CA; n  = 185 patients) was treated before and cohort B (CB; n  = 58 patients) after implementation of PPVGFM. Both cohorts were compared regarding postoperative complications. Results Ultrasevere complications (G4/G5) were exclusively present in CA ( p  = 0.0025). No difference between cohorts was observed regarding severe complications (G3–G5) ( p  = 0.062). Median positive fluid excess was lower in CB ( p  = 0.001). This was independent of tumor load [peritoneal cancer index] ( p  = 0.001) and FIGO stage ( p  = 0.001). Time to first postoperative defecation was shorter in CB (CB: d2 median versus CA: d3 median; p  = 0.001). CB had a shorter length of hospital stay ( p  = 0.003), less requirement of intensive medical care ( p  = 0.001) and postoperative ventilation ( p  = 0.001). CB received higher doses of noradrenalin ( p  = 0.001). In the combined study cohort, there were more severe complications (G3–G5) in the case of a PFE ≥ 3000 ml ( p  = 0.034) and significantly more anastomotic leakage in the case of a PFE ≥ 4000 ml ( p  = 0.006). Conclusions Intraoperative fluid reduction in ovarian cancer surgery according to a PPVGFM is safe and significantly reduces ultrasevere postoperative complications. PFEs of ≥ 3000 ml and ≥ 4000 ml were identified as cutoffs for significantly more severe complications and anastomotic leakage, respectively.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anastomotic leak</subject><subject>Anastomotic Leak - etiology</subject><subject>Cancer surgery</subject><subject>Complications</subject><subject>Cytoreduction Surgical Procedures - adverse effects</subject><subject>Defecation</subject><subject>Female</subject><subject>Fluid Therapy</subject><subject>Follow-Up Studies</subject><subject>Gynecologic Oncology</subject><subject>Humans</subject><subject>Intraoperative Complications - etiology</subject><subject>Length of Stay</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Middle Aged</subject><subject>Oncology</subject><subject>Ovarian cancer</subject><subject>Ovarian Neoplasms - pathology</subject><subject>Ovarian Neoplasms - surgery</subject><subject>Patients</subject><subject>Postoperative</subject><subject>Postoperative Complications - etiology</subject><subject>Prognosis</subject><subject>Retrospective Studies</subject><subject>Surgery</subject><subject>Surgical anastomosis</subject><subject>Surgical Oncology</subject><subject>Water-Electrolyte Balance</subject><issn>1068-9265</issn><issn>1534-4681</issn><issn>1534-4681</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><recordid>eNp9UU1PHDEMjVCrQmn_AIdqpF64TMn3JKeqrEqLhAQSlGuUzXho0GyyTXZW4t_jZfkoPfSU2H5-9vMj5IDRL4xLdVQZlUK2lMuWaS51S3fIHlOYktqwN_in2rSWa7VL3td6SynrBFXvyK6worOdMXvk-jStis9LKH4V19CcjFPsm2M_-hSg8alvLqDEl_osL5ZjDBjkVJuYmvO1L9GnZrZpKM3lVG6g3H0gbwc_Vvj4-O6TXyffr2Y_27PzH6ezb2dtEEqvWi64AS7U0IOhprcqUD9YOwcMAipifTcPAxigUloGc2YH5aXsIPAAWg5in3zd8i6n-QL6ABs1o1uWuPDlzmUf3etKir_dTV47xhQyWooMh48MJf-ZoK7cItYAIx4A8lSdYAxnWys1Qj__A73NU0moD1FcM2M5NYjiW1QoudYCw_M2jLqNb27rm0Pf3INvbrPFp791PLc8GYUAsQVULCU88cvs_9DeA3hGpM8</recordid><startdate>20241201</startdate><enddate>20241201</enddate><creator>Egger, Eva K.</creator><creator>Ullmann, Janina</creator><creator>Hilbert, Tobias</creator><creator>Ralser, Damian J.</creator><creator>Padron, Laura Tascon</creator><creator>Marinova, Milka</creator><creator>Stope, Matthias</creator><creator>Mustea, Alexander</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-9891-3996</orcidid></search><sort><creationdate>20241201</creationdate><title>Intraoperative Fluid Balance and Perioperative Complications in Ovarian Cancer Surgery</title><author>Egger, Eva K. ; Ullmann, Janina ; Hilbert, Tobias ; Ralser, Damian J. ; Padron, Laura Tascon ; Marinova, Milka ; Stope, Matthias ; Mustea, Alexander</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-2328e235fde808d95c0af99be08dc2461d7bcfe8e04491eb19f5a447ec2ce64f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anastomotic leak</topic><topic>Anastomotic Leak - etiology</topic><topic>Cancer surgery</topic><topic>Complications</topic><topic>Cytoreduction Surgical Procedures - adverse effects</topic><topic>Defecation</topic><topic>Female</topic><topic>Fluid Therapy</topic><topic>Follow-Up Studies</topic><topic>Gynecologic Oncology</topic><topic>Humans</topic><topic>Intraoperative Complications - etiology</topic><topic>Length of Stay</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Middle Aged</topic><topic>Oncology</topic><topic>Ovarian cancer</topic><topic>Ovarian Neoplasms - pathology</topic><topic>Ovarian Neoplasms - surgery</topic><topic>Patients</topic><topic>Postoperative</topic><topic>Postoperative Complications - etiology</topic><topic>Prognosis</topic><topic>Retrospective Studies</topic><topic>Surgery</topic><topic>Surgical anastomosis</topic><topic>Surgical Oncology</topic><topic>Water-Electrolyte Balance</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Egger, Eva K.</creatorcontrib><creatorcontrib>Ullmann, Janina</creatorcontrib><creatorcontrib>Hilbert, Tobias</creatorcontrib><creatorcontrib>Ralser, Damian J.</creatorcontrib><creatorcontrib>Padron, Laura Tascon</creatorcontrib><creatorcontrib>Marinova, Milka</creatorcontrib><creatorcontrib>Stope, Matthias</creatorcontrib><creatorcontrib>Mustea, Alexander</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Annals of surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Egger, Eva K.</au><au>Ullmann, Janina</au><au>Hilbert, Tobias</au><au>Ralser, Damian J.</au><au>Padron, Laura Tascon</au><au>Marinova, Milka</au><au>Stope, Matthias</au><au>Mustea, Alexander</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intraoperative Fluid Balance and Perioperative Complications in Ovarian Cancer Surgery</atitle><jtitle>Annals of surgical oncology</jtitle><stitle>Ann Surg Oncol</stitle><addtitle>Ann Surg Oncol</addtitle><date>2024-12-01</date><risdate>2024</risdate><volume>31</volume><issue>13</issue><spage>8944</spage><epage>8951</epage><pages>8944-8951</pages><issn>1068-9265</issn><issn>1534-4681</issn><eissn>1534-4681</eissn><abstract>Background Fluid overload and hypovolemia promote postoperative complications in patients undergoing cytoreductive surgery for ovarian cancer. In the present study, postoperative complications and anastomotic leakage were investigated before and after implementation of pulse pressure variation-guided fluid management (PPVGFM) during ovarian cancer surgery. Patients and Methods A total of n  = 243 patients with ovarian cancer undergoing cytoreductive surgery at the University Hospital Bonn were retrospectively evaluated. Cohort A (CA; n  = 185 patients) was treated before and cohort B (CB; n  = 58 patients) after implementation of PPVGFM. Both cohorts were compared regarding postoperative complications. Results Ultrasevere complications (G4/G5) were exclusively present in CA ( p  = 0.0025). No difference between cohorts was observed regarding severe complications (G3–G5) ( p  = 0.062). Median positive fluid excess was lower in CB ( p  = 0.001). This was independent of tumor load [peritoneal cancer index] ( p  = 0.001) and FIGO stage ( p  = 0.001). Time to first postoperative defecation was shorter in CB (CB: d2 median versus CA: d3 median; p  = 0.001). CB had a shorter length of hospital stay ( p  = 0.003), less requirement of intensive medical care ( p  = 0.001) and postoperative ventilation ( p  = 0.001). CB received higher doses of noradrenalin ( p  = 0.001). In the combined study cohort, there were more severe complications (G3–G5) in the case of a PFE ≥ 3000 ml ( p  = 0.034) and significantly more anastomotic leakage in the case of a PFE ≥ 4000 ml ( p  = 0.006). Conclusions Intraoperative fluid reduction in ovarian cancer surgery according to a PPVGFM is safe and significantly reduces ultrasevere postoperative complications. PFEs of ≥ 3000 ml and ≥ 4000 ml were identified as cutoffs for significantly more severe complications and anastomotic leakage, respectively.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>39379788</pmid><doi>10.1245/s10434-024-16246-0</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-9891-3996</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1068-9265
ispartof Annals of surgical oncology, 2024-12, Vol.31 (13), p.8944-8951
issn 1068-9265
1534-4681
1534-4681
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11549190
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Adult
Aged
Aged, 80 and over
Anastomotic leak
Anastomotic Leak - etiology
Cancer surgery
Complications
Cytoreduction Surgical Procedures - adverse effects
Defecation
Female
Fluid Therapy
Follow-Up Studies
Gynecologic Oncology
Humans
Intraoperative Complications - etiology
Length of Stay
Medicine
Medicine & Public Health
Middle Aged
Oncology
Ovarian cancer
Ovarian Neoplasms - pathology
Ovarian Neoplasms - surgery
Patients
Postoperative
Postoperative Complications - etiology
Prognosis
Retrospective Studies
Surgery
Surgical anastomosis
Surgical Oncology
Water-Electrolyte Balance
title Intraoperative Fluid Balance and Perioperative Complications in Ovarian Cancer Surgery
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T21%3A49%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intraoperative%20Fluid%20Balance%20and%20Perioperative%20Complications%20in%20Ovarian%20Cancer%20Surgery&rft.jtitle=Annals%20of%20surgical%20oncology&rft.au=Egger,%20Eva%20K.&rft.date=2024-12-01&rft.volume=31&rft.issue=13&rft.spage=8944&rft.epage=8951&rft.pages=8944-8951&rft.issn=1068-9265&rft.eissn=1534-4681&rft_id=info:doi/10.1245/s10434-024-16246-0&rft_dat=%3Cproquest_pubme%3E3114499946%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3126189208&rft_id=info:pmid/39379788&rfr_iscdi=true